DioGenix, Inc. - Product Pipeline Analysis, 2014 Update - New Market Report
DioGenix, Inc. (DGx) is a molecular diagnostics company. The company develops and commercializes diagnostic, prognostic and treatment response monitoring tests. Its MSPrecise is a test for the diagnosis of multiple sclerosis, which measures codon replacement frequencies in the variable region of immunoglobulin heavy chain genes in B cells. DGx uses next-generation sequencing to measure DNA mutations. The company offers products for the diagnosis and monitoring of neurological and neurodegenerative diseases, such as neuro-sarcoid, neuromyelitis optica, paraneoplastic disease and lupus with...
View full press release